3-191275281-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_198152.5(UTS2B):c.305G>T(p.Gly102Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_198152.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UTS2B | NM_198152.5 | c.305G>T | p.Gly102Val | missense_variant | 8/9 | ENST00000340524.10 | NP_937795.2 | |
UTS2B | XM_017006091.2 | c.305G>T | p.Gly102Val | missense_variant | 7/8 | XP_016861580.1 | ||
UTS2B | XM_011512631.3 | c.305G>T | p.Gly102Val | missense_variant | 7/8 | XP_011510933.1 | ||
UTS2B | XM_047447899.1 | c.305G>T | p.Gly102Val | missense_variant | 7/8 | XP_047303855.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152138Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 251056Hom.: 0 AF XY: 0.0000590 AC XY: 8AN XY: 135676
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461112Hom.: 0 Cov.: 29 AF XY: 0.0000124 AC XY: 9AN XY: 726858
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152138Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2024 | The c.305G>T (p.G102V) alteration is located in exon 8 (coding exon 4) of the UTS2B gene. This alteration results from a G to T substitution at nucleotide position 305, causing the glycine (G) at amino acid position 102 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at